NCT03433859View on ClinicalTrials.gov

Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs)

PHASE3CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

September 10, 2020

Study Completion Date

March 3, 2021

Conditions
HyperhidrosisResidual Limbs
Interventions
DRUG

OnabotulinumtoxinA

OnabotulinumtoxinA in intradermal Injections on residual lower limb : 100 Units - 1 dose

OTHER

Topical Aluminium Chloride (cosmetic product)

Topical Aluminium Chloride (cosmetic product) : 1 quantity sufficient on the lower limb

Trial Locations (9)

13384

Hopital Laveran, Marseille

29240

Hôpital Clermont-Tonnerre, Brest

33523

CMPR La Tour de Gassies, Bruges

35043

Pôle Saint Helier, Rennes

44818

Centre La Tourmaline, Saint-Herblain

49103

Les Capucins, Angers

67082

Institut Universitaire de Réadaptation Clémenceau, Strasbourg

92141

Hopital Percy, Clamart

94460

Institut Robert Merle d'Aubigné, IRMA, Valenton

All Listed Sponsors
lead

Direction Centrale du Service de Santé des Armées

OTHER

NCT03433859 - Topical Aluminium Chloride vs OnabotulinumtoxinA Intradermal Injections in Residual Limb Hyperhidrosis (Lower Limbs) | Biotech Hunter | Biotech Hunter